MétaCan
Menu
Back to cohort

Abstract B220: Artificially inducing protein-membrane anchorage: Introducing a new therapeutic modality.

2011· article· en· W2052027458 on OpenAlexaff
Miriam Avadisian, Steven Fletcher, Baoxu Liu, Wei Zhao, Peibin Yue, James Turkson, Claudiu C. Gradinaru, Patrick T. Gunning

Bibliographic record

VenueMolecular Cancer Therapeutics · 2011
Typearticle
Languageen
FieldChemistry
TopicClick Chemistry and Applications
Canadian institutionsUniversity of Toronto
Fundersnot available
KeywordsCell biologyCancer cellSTAT3PrenylationSTAT proteinMembrane proteinGene knockdownTarget proteinChemistryBiologyBiochemistryCancerMembraneSignal transductionGeneEnzyme

Abstract

fetched live from OpenAlex

Abstract We aim to develop an innovative therapeutic modality of inhibiting aberrant protein function through suppression of activation and/or nuclear translocation. Nature has developed prenylation, a post-translational modification that covalently attaches a hydrophobic prenyl group to a protein to facilitate protein-membrane association to the plasma membrane. We hypothesize that mimicking Nature by artificially inducing protein-membrane anchorage through the use of a rationally designed protein-membrane anchor (PMA), we can simultaneously inhibit the activation and nuclear translocation of oncogenic proteins. Our aim is to explore the therapeutic potential of the protein-membrane anchor and potentially develop a novel drug modality that can be utilized by cancer patients. Our proof-of-concept PMA was design to target signal transducer and activator of transcription 3 (Stat3) protein. Constitutively-active Stat3 directly contributes to the progression of cancer and is present in numerous human cancers. A number of studies have shown that down-regulation of this oncogene via iRNA knockdown induces cellular apoptosis. Thus, Stat3 is an attractive target for the development of potent anti-cancer therapeutics for cancer. Our proto-type PMA 1 was composed of two binding modules: a recognition motif to bind the protein and an anchor to sequester the protein complex to the membrane. The PMA was comprised of a potent Stat3 recognition sequence GpYLPQTV-NH2 covalently attached to a cholesterol membrane anchor. We tested the ability of our PMA to anchor Stat3 to the cell membrane in MDA-MB-231 breast cancer cells which are known to have constitutively-active Stat3. We immunostained these cells with membrane stain FM-4–64 (red), anti-Stat3 antibody (green) and DAPI (nucleus, blue). In the absence of PMA 1, there was strong Stat3 nuclear presence. Most excitingly, in the presence of 25 μM concentration PMA 1, we observed complete sequestration of Stat3 to the cell membrane through PMA-Stat3 association. Currently, we are designing and synthesizing more drug-like, nonphosphorylated PMAs that are less prone to metabolic degradation. We will conduct further studies to determine the biochemical and biological utility of these PMAs. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2011 Nov 12-16; San Francisco, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2011;10(11 Suppl):Abstract nr B220.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.052
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.290
Teacher spread0.234 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueMolecular Cancer TherapeuticsSame topicClick Chemistry and ApplicationsFrench-language works237,207